SCHEMBL4677347

SCHEMBL4677347

CCOC(=O)C(C)(C)Oc1ccc(CNC)cc1Cl

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FBP1 P09467 9/20 0.55
TSHR P16473 3/20 0.49
PPARA Q07869 2/20 0.49
ABCB11 O95342 1/20 0.49
CYP1A2 P05177 1/20 0.49
CYP3A4 P08684 1/20 0.49
HTR2A P28223 1/20 0.49
PMP22 Q01453 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.47
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45
OPRK1 P41145 1/20 0.43
PPARG P37231 1/20 0.40
S1PR2 O95136 1/20 0.39
S1PR1 P21453 1/20 0.39
S1PR3 Q99500 1/20 0.39
LPAR2 Q9HBW0 1/20 0.39
SLC6A2 P23975 1/20 0.38
SLC6A4 P31645 1/20 0.38
SLC6A3 Q01959 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4683046 0.87 FBP1 (0.53) FBP1TSHRPPARAABCB11CYP1A2
SCHEMBL4679282 0.86 FBP1 (0.51) FBP1TSHRPPARAABCB11CYP1A2
SCHEMBL4735992 0.86 FBP1 (0.51) FBP1TSHRPPARAABCB11CYP1A2
SCHEMBL4678053 0.86 FBP1 (0.58) FBP1TSHRPPARAABCB11CYP1A2
SCHEMBL14445931 0.85 FBP1 (0.50) FBP1TSHRPPARAABCB11CYP1A2
SCHEMBL4682002 0.85 FBP1 (0.57) FBP1TSHRPPARAABCB11CYP1A2
SCHEMBL14445933 0.84 FBP1 (0.52) FBP1TSHRPPARAABCB11CYP1A2
SCHEMBL6740992 0.82 FBP1 (0.55) FBP1TSHRPPARAABCB11CYP1A2
SCHEMBL581322 0.81 TSHR (0.64) FBP1TSHRPPARAABCB11CYP1A2
SCHEMBL3585865 0.80 FBP1 (0.60) FBP1TSHRPPARAABCB11CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1513796-B1 PHENYLOXYALKANOIC ACID DERIVATIVES AS HPPAR ACTIVATORS SMITHKLINE BEECHAM CORP (US) 2008-02-13 EP disclosed
US-7241793-B2 Phenyloxyalkanonic acid derivatives as hPPAR activators SMITHKLINE BEECHAM CORPORATION (US) 2007-07-10 US disclosed
US-7241793-B2 Phenyloxyalkanonic acid derivatives as hPPAR activators SMITHKLINE BEECHAM CORPORATION (US) 2007-07-10 US disclosed
US-7241793-B2 Phenyloxyalkanonic acid derivatives as hPPAR activators SMITHKLINE BEECHAM CORPORATION (US) 2007-07-10 US disclosed
US-20050222424-A1 Phenyloxyalkanonic acid derivatives as hppar activators SMITHKLINE BEECHAM CORPORATION 2005-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050222424-A1 Phenyloxyalkanonic acid derivatives as hppar activators CEL, HPN, LIPA FBP1 393/4885TSHR 2419/4885PPARA 54/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.